Al18F-NOTA-LM3 PET/CT in Patients With TIO

Recruiting now · Not applicable

Conditions studied: Tumor-Induced Osteomalacia

In brief

This is a pilot study to assess the value of whole-body Al18F-NOTA-LM3 PET/CT in patients with tumor-induced osteomalacia.

Key facts

Study ID

NCT07366099

Run by

Peking Union Medical College Hospital

People needed

40

Starts

2023-03-30

Expected to finish

2026-05-30

Last updated by the study team

2026-01-26

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 18 to 80 years.
• Suspected or confirmed TIO patients.

You may not qualify if…

• Combined with other types of tumors.
• Severe liver or renal dysfunction (ALT/AST≥5 ULN, GFR<30ml/min).
• Pregnant or breast-feeding women.
• Inability to perform PET/CT scans.

Where it is running

• Peking Union Medical College Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.